Eargo Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eargo in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Eargo stock.
View analyst ratings for Eargo or view top-rated stocks.

Wall Street analysts have given Eargo a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Eargo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Eargo is scheduled to release its next quarterly earnings announcement on Thursday, November 18th 2021.
View our earnings forecast for Eargo.

Eargo, Inc. (NASDAQ:EAR) announced its quarterly earnings data on Thursday, August, 12th. The company reported ($0.36) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) by $0.11. Eargo had a negative trailing twelve-month return on equity of 39.32% and a negative net margin of 52.33%.
View Eargo's earnings history.

Eargo issued an update on its FY 2021 earnings guidance on Thursday, September, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $93 million-$96 million, compared to the consensus revenue estimate of $91.97 million.

4 equities research analysts have issued 1-year price objectives for Eargo's stock. Their forecasts range from $41.00 to $52.00. On average, they anticipate Eargo's share price to reach $45.33 in the next year. This suggests a possible upside of 106.3% from the stock's current price.
View analysts' price targets for Eargo or view top-rated stocks among Wall Street analysts.

Some companies that are related to Eargo include Establishment Labs (ESTA), Avanos Medical (AVNS), Inogen (INGN), D8 (DEH), Sientra (SIEN), Conformis (CFMS), Sanara MedTech (SMTI), United Health Products (UEEC), Invacare (IVC), Lakeland Industries (LAKE), Surgalign (SRGA), Milestone Scientific (MLSS), Alpha Pro Tech (APT), CollPlant Biotechnologies (CLGN) and Predictive Oncology (POAI).
View all of EAR's competitors.

(EAR) raised $100 million in an initial public offering (IPO) on Friday, October 16th 2020. The company issued 6,700,000 shares at $14.00-$16.00 per share. J.P.Morgan and BofA Securities served as the underwriters for the IPO and Wells Fargo Securities and William Blair were co-managers.

Eargo trades on the NASDAQ under the ticker symbol "EAR."

Eargo's stock is owned by a variety of retail and institutional investors. Top institutional investors include NEA Management Company LLC (11.67%), BlackRock Inc. (8.30%), Vanguard Group Inc. (4.26%), Alliancebernstein L.P. (3.63%), Millennium Management LLC (2.74%) and Victory Capital Management Inc. (2.42%). Company insiders that own Eargo stock include Adam Laponis, Geoff Pardo, Healthcare Holding BV Gilde, Mohamad Makhzoumi and Nina Richardson.
View institutional ownership trends for Eargo.

EAR stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Invesco Ltd., Wells Fargo & Company MN, Marshall Wace LLP, Marshall Wace LLP, Marshall Wace North America L.P., Russell Investments Group Ltd., and Osterweis Capital Management Inc.. Company insiders that have sold Eargo company stock in the last year include Adam Laponis, Geoff Pardo, Healthcare Holding BV Gilde, Mohamad Makhzoumi, and Nina Richardson.
View insider buying and selling activity for Eargo or view top insider-selling stocks.

EAR stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Millennium Management LLC, Vanguard Group Inc., Victory Capital Management Inc., Morgan Stanley, Morgan Stanley, State Street Corp, and Capital International Investors.
View insider buying and selling activity for Eargo or or view top insider-buying stocks.

Shares of EAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EAR stock can currently be purchased for approximately $21.97.

Eargo has a market capitalization of $860.35 million and generates $69.15 million in revenue each year. The company earns $-39,850,000.00 in net income (profit) each year or ($3.80) on an earnings per share basis.

Eargo employs 238 workers across the globe.

The official website for Eargo is eargo.com.

The company can be reached via phone at 650-351-7700 or via email at [email protected].